Melanie Rietenbach

Global Product Manager, Immunotherapy  • Miltenyi Biotec

Melanie Rietenbach is Global Product Manager for the Immunotherapy portfolio at Miltenyi Biotec. During the 3 years, she has been working together with the R&D and Clinical Development Team in order to advance the development of tools to enable engineered T cell immunotherapy. Before that, Melanie already supported Miltenyi Biotec in her role as Application Development Specialist and Clinical Product Specialist for more than three years. During that time, she was responsible for technical support and application training on Miltenyi Biotec’s clinical product portfolio with  focus on cell and gene therapy applications and related products

Also Speaking

Mark Trusheim

Strategic Director, NEWDIGS Initiative Institute for Clinical Research and Health Policy Studies • Tufts Medical Center

Samik Basu

Chief Scientific Officer • Cabaletta Bio

Jacqueline Barry

Chief Clinical Officer • Cell and Gene Therapy Catapult

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.